• Network Structure enhances access to improved Data Potential
    Simon Meffan-Main
  • Graham McGibbon
  • Alan Millar, Vice President of Business Development, Tetra Partner Network

News & Views

Network Structure enhances access to improved Data Potential

Aug 03 2022

R&D software provider ACD/Labs had signed up to the Tetra Partner Network, a platform developed by scientific data cloud company TetraScience, which aims to help pharma and biopharma to achieve greater insights into acquired data and potentially improved outcomes.

几十年来,ACD/Labs一直在帮助科学家在单一环境中收集来自主要仪器供应商的多技术分析数据。Spectrus平台能够存储和管理带有化学背景的数字解释和专家注释,通过自动化数据编组加快常规数据分析,提高数据的可访问性和完整性。

该伙伴关系网络平台生产的Tetra Data生产供应商不可知的、液体的和公平(可查找、可访问、可互操作、可重复使用)的科学数据,可以在制药和生物制药管道中进行搜索、访问和分析。利乐合作伙伴网络副总裁Simon Meffan-Main博士指出,将这种能力与ACD/Labs的特性相结合,领先的优化和解读产品将使客户能够加快工作流程,并更有特异性地分析科学数据。他补充说:“我们很高兴能与ACD/Labs合作,他们在研发中创新客户使用分析数据分析的方式方面有着悠久的历史。”

"Solutions from ACD/Labs and TetraScience work to remove the burden of data management from the scientist's workflow and make the IT function more effective," said Graham McGibbon, Director of Strategic Partnerships, ACD/Labs. "We share a common goal of creating unrestricted innovation for scientists and IT departments and are delighted to be part of the Tetra Partner Network."

“各种行业参与者——全球制药公司、生物技术初创公司、信息学提供商、CROs、生物制药应用公司等等——都认识到,向科学数据云的运动必须由供应商中立和以数据为中心的开放合作伙伴推动,”TetraScience首席执行官Patrick Grady解释说。“生物制药公司需要在云端统一和协调实验数据,以便充分利用人工智能和数据科学的力量。反过来,人工智能和数据科学将揭示深刻的见解,加速延长和改善人类生命的治疗方法的发现和开发。我们很高兴能与ACD/Labs一起进一步扩展这个网络。"

More informationonline